Last $22.24 USD
Change Today +0.13 / 0.59%
Volume 20.6K
EXAC On Other Exchanges
As of 8:10 PM 01/23/15 All times are local (Market data is delayed by at least 15 minutes).

exactech inc (EXAC) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/30/14 - $26.52
52 Week Low
10/14/14 - $19.87
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for EXACTECH INC (EXAC)

Related News

No related news articles were found.

exactech inc (EXAC) Related Businessweek News

No Related Businessweek News Found

exactech inc (EXAC) Details

Exactech, Inc. develops, manufactures, markets, and distributes orthopedic implant devices; and related surgical instrumentation, supplies, and biologic materials to hospitals and physicians in the United States and internationally. It offers knee implant systems that address orthopedic surgeons’ concerns for contact stress, patellar tracking, polyethylene wear, joint stability, bone preservation, and instrumentation; extremities products comprising Equinoxe, a platform shoulder system for the treatment of degenerative disease and trauma; and hip implant systems that address hip arthroplasty, hip fractures, and complex primary hip surgeries. The company also offers biologics and spine products for the healing and regeneration of bone and soft tissues; distributes allograft tissue implants for oral and dental applications; and markets tri-calcium phosphate/hydroxyapatite based synthetic bone graft substitutes. In addition, it offers Ossigen, a 3D matrix of collagen and an organic bone mineral processed into blocks for surgical implantation for the repair of bony defects in the spine, extremities, and pelvis; hip, knee, and shoulder spacers that are used in two stage revision procedures; an air-driven impact handpiece that surgeons could use during joint implant revision procedures to remove failed prostheses and bone cement; and bone cement systems. The company markets its orthopedic implant products through a network of independent sales agencies, direct sales representatives, and independent distributors to hospitals, surgeons and other physicians, and clinics. Exactech, Inc. was founded in 1985 and is headquartered in Gainesville, Florida.

608 Employees
Last Reported Date: 03/6/14
Founded in 1985

exactech inc (EXAC) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $387.8K
Co-Founder and Executive Chairman
Total Annual Compensation: $615.8K
Co-Founder and Executive Vice President of Re...
Total Annual Compensation: $325.4K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $380.6K
Senior Vice President and General Manager of ...
Total Annual Compensation: $391.3K
Compensation as of Fiscal Year 2013.

exactech inc (EXAC) Key Developments

Exactech Launches Octane(R) Elevate Peek Spacer System for Lumbar Interbody Fusion Procedures

Exactech Inc. announced that its spine division has launched Octane(R) Elevate, a Poly Ether Ether Ketone (PEEK) spacer system, at the North American Spine Society Annual Meeting (NASS). With the introduction of Octane Elevate, an innovative, self-distracting lumbar fusion device, surgeons can restore disc height while addressing various anatomical conditions and degrees of degeneration. Octane Elevate is designed to be implanted with less force, potentially reducing incidence of vertebrae and nerve damage. A unique feature of the product's design and instrumentation allows surgeons to backfill the interbody spacer with autogenous bone graft, which is designed to aid in fusion. Octane Elevate's versatility is highlighted through its multiple footprint options and heights available in 1mm increments.

Exactech Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Provides Earnings Guidance for the Fourth Quarter and Fiscal Year 2014

Exactech Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported net income of $3 million or $0.21 per diluted share, compared with the prior-year period's $3.2 million, or $0.23 per diluted share. Revenue was $57.9 million, up 4% from $55.7 million in the same quarter last year. Income from operations was $5.52 million compared to $4.84 million a year ago. Income before income taxes was $4.62 million compared to $4.85 million a year ago. For the nine months, the company reported net sales of $185.06 million compared to $175.51 million a year ago. Income from operations was $18.94 million compared to $17.12 million a year ago. Income before income taxes was $17.70 million compared to $16.03 million a year ago. Net income was $11.37 million or $0.81 per diluted share, compared with the prior-year period's $10.78 million, or $0.79 per diluted share. The company provided earnings guidance for the fourth quarter and fiscal year 2014. For fourth quarter, the company anticipates EPS of $0.33 - $0.35 on revenue of $62 million - $64 million. For the year, the company now expects fiscal 2014 EPS of $1.14 - $1.16 on revenue of $247 million - $249 million.

Exactech Inc. to Report Q3, 2014 Results on Oct 21, 2014

Exactech Inc. announced that they will report Q3, 2014 results at 8:15 PM, GMT Standard Time on Oct 21, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXAC:US $22.24 USD 0.00

EXAC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aerovironment Inc $25.70 USD -0.16
API Technologies Corp $2.02 USD +0.11
Mercury Systems Inc $14.66 USD -0.08
RTI Surgical Inc $4.71 USD -0.11
SMTC Corp $1.69 USD +0.0101
View Industry Companies

Industry Analysis


Industry Average

Valuation EXAC Industry Range
Price/Earnings 19.4x
Price/Sales 1.2x
Price/Book 1.5x
Price/Cash Flow 9.3x
TEV/Sales 1.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXACTECH INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at